Beijing Tiantan Biological Products Co., Ltd. (600161.SS) SHH

Currency In CNY

AD

Valuation

Market Cap32.31B
Enterprise Value30.51B
P/E Ratio31.39
PEG Ratio-0.67
Price/Sales Ratio4.26
Price/Book Ratio2
Enterprise/Revenue3.9
Enterprise/EBITDA13.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.13
Operating Margin0.23
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue6.14B
Revenue/Share2.84
Gross Profit2.58B
EBITDA2.29B
Net Income1.09B
Diluted EPS0.55

Balance Sheet

Total Cash2.17B
Total Cash/Share1.1
Total Debt168.42M
Total Debt/Equity0.01
Current Ratio6.98
Book Value Per Share7.92

Price History

52-Week Change-39.15
52-Week High19.93
52-Week Low11.12
Moving Average 50 Days12.42
Moving Average 200 Days14.51

Statistics

Average Volume15.37M
Shares Outstanding1.98B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield1.65
Payout Ratio0.65
Last Split Factor6:5
Last Split DateJune 20, 2024
AD